253 related articles for article (PubMed ID: 33613109)
21. Fangchinoline induces gallbladder cancer cell apoptosis by suppressing PI3K/Akt/XIAP axis.
Li J; Cen W; Tong C; Wang L; Zhang W; Deng S; Yu J; Lu B
PLoS One; 2022; 17(4):e0266738. PubMed ID: 35446864
[TBL] [Abstract][Full Text] [Related]
22. Long noncoding RNA H19 contributes to gallbladder cancer cell proliferation by modulated miR-194-5p targeting AKT2.
Wang SH; Wu XC; Zhang MD; Weng MZ; Zhou D; Quan ZW
Tumour Biol; 2016 Jul; 37(7):9721-30. PubMed ID: 26803515
[TBL] [Abstract][Full Text] [Related]
23. SNORA74B gene silencing inhibits gallbladder cancer cells by inducing PHLPP and suppressing Akt/mTOR signaling.
Qin Y; Meng L; Fu Y; Quan Z; Ma M; Weng M; Zhang Z; Gao C; Shi X; Han K
Oncotarget; 2017 Mar; 8(12):19980-19996. PubMed ID: 28212545
[TBL] [Abstract][Full Text] [Related]
24. Contribution of the PI3K/MMPs/Ln-5γ2 and EphA2/FAK/Paxillin signaling pathways to tumor growth and vasculogenic mimicry of gallbladder carcinomas.
Lu XS; Sun W; Ge CY; Zhang WZ; Fan YZ
Int J Oncol; 2013 Jun; 42(6):2103-15. PubMed ID: 23588386
[TBL] [Abstract][Full Text] [Related]
25. Norcantharidin inhibits tumor growth and vasculogenic mimicry of human gallbladder carcinomas by suppression of the PI3-K/MMPs/Ln-5γ2 signaling pathway.
Zhang JT; Sun W; Zhang WZ; Ge CY; Liu ZY; Zhao ZM; Lu XS; Fan YZ
BMC Cancer; 2014 Mar; 14():193. PubMed ID: 24628713
[TBL] [Abstract][Full Text] [Related]
26. Oroxylin A Exerts Its Antitumor Effects in Human Gallbladder Cancer via Inhibition of the PTEN/PI3K/AKT Signaling Pathway.
Xuan L; Zhang J; Ji J; Hu J; Li F
Biol Pharm Bull; 2020; 43(10):1511-1518. PubMed ID: 32999161
[TBL] [Abstract][Full Text] [Related]
27. Long non-coding RNA CRNDE promotes gallbladder carcinoma carcinogenesis and as a scaffold of DMBT1 and C-IAP1 complexes to activating PI3K-AKT pathway.
Shen S; Liu H; Wang Y; Wang J; Ni X; Ai Z; Pan H; Liu H; Shao Y
Oncotarget; 2016 Nov; 7(45):72833-72844. PubMed ID: 27637083
[TBL] [Abstract][Full Text] [Related]
28. Knockdown of TRIM31 suppresses proliferation and invasion of gallbladder cancer cells by down-regulating MMP2/9 through the PI3K/Akt signaling pathway.
Li H; Zhang Y; Hai J; Wang J; Zhao B; Du L; Geng X
Biomed Pharmacother; 2018 Jul; 103():1272-1278. PubMed ID: 29864908
[TBL] [Abstract][Full Text] [Related]
29. Unravelling of the comparative Transcriptomic Profile of Gallbladder Cancer using mRNA sequencing.
Dixit R; Pandey M; Rajput M; Shukla VK
Mol Biol Rep; 2022 Jul; 49(7):6395-6403. PubMed ID: 35469389
[TBL] [Abstract][Full Text] [Related]
30. Yes-associated protein 1 (YAP1) promotes human gallbladder tumor growth via activation of the AXL/MAPK pathway.
Li M; Lu J; Zhang F; Li H; Zhang B; Wu X; Tan Z; Zhang L; Gao G; Mu J; Shu Y; Bao R; Ding Q; Wu W; Dong P; Gu J; Liu Y
Cancer Lett; 2014 Dec; 355(2):201-9. PubMed ID: 25218593
[TBL] [Abstract][Full Text] [Related]
31. miR-4461 inhibits the progression of Gallbladder carcinoma via regulating EGFR/AKT signaling.
Yan X; Yang P; Liu H; Zhao Y; Wu Z; Zhang B
Cell Cycle; 2022 Jun; 21(11):1166-1177. PubMed ID: 35196196
[TBL] [Abstract][Full Text] [Related]
32. BRD4 inhibitor and histone deacetylase inhibitor synergistically inhibit the proliferation of gallbladder cancer in vitro and in vivo.
Liu S; Li F; Pan L; Yang Z; Shu Y; Lv W; Dong P; Gong W
Cancer Sci; 2019 Aug; 110(8):2493-2506. PubMed ID: 31215139
[TBL] [Abstract][Full Text] [Related]
33. Upregulation of Long Noncoding RNA_GAS5 Suppresses Cell Proliferation and Metastasis in Laryngeal Cancer via Regulating PI3K/AKT/mTOR Signaling Pathway.
Liu W; Zhan J; Zhong R; Li R; Sheng X; Xu M; Lu Z; Zhang S
Technol Cancer Res Treat; 2021; 20():1533033821990074. PubMed ID: 33641529
[TBL] [Abstract][Full Text] [Related]
34. Overexpressed microRNA-136 works as a cancer suppressor in gallbladder cancer through suppression of JNK signaling pathway via inhibition of MAP2K4.
Niu J; Li Z; Li F
Am J Physiol Gastrointest Liver Physiol; 2019 Nov; 317(5):G670-G681. PubMed ID: 31369289
[TBL] [Abstract][Full Text] [Related]
35. Long noncoding RNA HEGBC promotes tumorigenesis and metastasis of gallbladder cancer via forming a positive feedback loop with IL-11/STAT3 signaling pathway.
Yang L; Gao Q; Wu X; Feng F; Xu K
J Exp Clin Cancer Res; 2018 Aug; 37(1):186. PubMed ID: 30086773
[TBL] [Abstract][Full Text] [Related]
36. Mir-20a-5p induced WTX deficiency promotes gastric cancer progressions through regulating PI3K/AKT signaling pathway.
Li J; Ye D; Shen P; Liu X; Zhou P; Zhu G; Xu Y; Fu Y; Li X; Sun J; Xu J; Zhang Q
J Exp Clin Cancer Res; 2020 Oct; 39(1):212. PubMed ID: 33032635
[TBL] [Abstract][Full Text] [Related]
37. The E545K mutation of PIK3CA promotes gallbladder carcinoma progression through enhanced binding to EGFR.
Zhao S; Cao Y; Liu SB; Wang XA; Bao RF; Shu YJ; Hu YP; Zhang YJ; Jiang L; Zhang F; Liang HB; Li HF; Ma Q; Xu Y; Wang Z; Zhang YC; Chen L; Zhou J; Liu YB
J Exp Clin Cancer Res; 2016 Jun; 35(1):97. PubMed ID: 27317099
[TBL] [Abstract][Full Text] [Related]
38. Genomic
Li M; Liu F; Zhang F; Zhou W; Jiang X; Yang Y; Qu K; Wang Y; Ma Q; Wang T; Bai L; Wang Z; Song X; Zhu Y; Yuan R; Gao Y; Liu Y; Jin Y; Li H; Xiang S; Ye Y; Zhang Y; Jiang L; Hu Y; Hao Y; Lu W; Chen S; Gu J; Zhou J; Gong W; Zhang Y; Wang X; Liu X; Liu C; Liu H; Liu Y; Liu Y
Gut; 2019 Jun; 68(6):1024-1033. PubMed ID: 29954840
[TBL] [Abstract][Full Text] [Related]
39. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
[TBL] [Abstract][Full Text] [Related]
40. KIF15 knockdown suppresses gallbladder cancer development.
Wang J; Wang D; Fei Z; Feng D; Zhang B; Gao P; Hu G; Li W; Huang X; Chen D; Ding X; Wu W
Eur J Cell Biol; 2021; 100(7-8):151182. PubMed ID: 34781077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
